U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.55270-3T>C AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 4, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004017696.1

Allele description [Variation Report for NM_001267550.2(TTN):c.55270-3T>C]

NM_001267550.2(TTN):c.55270-3T>C

Genes:
TTN-AS1:TTN antisense RNA 1 [Gene - HGNC]
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.55270-3T>C
HGVS:
  • NC_000002.12:g.178601917A>G
  • NG_011618.3:g.233886T>C
  • NG_051363.1:g.84091A>G
  • NM_001256850.1:c.50347-3T>C
  • NM_001267550.2:c.55270-3T>CMANE SELECT
  • NM_003319.4:c.28075-3T>C
  • NM_133378.4:c.47566-3T>C
  • NM_133432.3:c.28450-3T>C
  • NM_133437.4:c.28651-3T>C
  • LRG_391:g.233886T>C
  • NC_000002.11:g.179466644A>G
  • NM_001267550.2:c.55270-3T>C
  • NM_003319.4:c.28075-3T>C
Links:
dbSNP: rs749109513
NCBI 1000 Genomes Browser:
rs749109513
Molecular consequence:
  • NM_001256850.1:c.50347-3T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001267550.2:c.55270-3T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_003319.4:c.28075-3T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133378.4:c.47566-3T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133432.3:c.28450-3T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133437.4:c.28651-3T>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000713807Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(May 4, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000713807.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The c.47566-3T>C variant in TTN has not been previously reported in individuals with cardiomyopathy but has been identified in 0.0008% (1/111878) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is located in the 3' splice region, but computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the c.47566-3T>C variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: PM2_Supporting, BP4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025